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Abstract
Background: Progress towards MDG4 in South Africa will depend largely on scaling up effective prevention
against mother to child transmission (PMTCT) of HIV and also addressing neonatal mortality. This imperative drives
increasing focus on the neonatal period and particularly on the development and testing of appropriate models of
sustainable, community-based care in South Africa in order to reach the poor. A number of key implementation
gaps affecting progress have been identified. Implementation gaps for HIV prevention in neonates; implementation
gaps for neonatal care especially home postnatal care; and implementation gaps for maternal mental health
support. We have developed and are evaluating and costing an integrated and scaleable home visit package
delivered by community health workers targeting pregnant and postnatal women and their newborns to provide
essential maternal/newborn care as well as interventions for Prevention of Mother to Child Transmission (PMTCT) of
HIV.
Methods: The trial is a cluster randomized controlled trial that is being implemented in Umlazi which is a peri-
urban settlement with a total population of 1 million close to Durban in KwaZulu Natal, South Africa. The trial
consists of 30 randomized clusters (15 in each arm). A baseline survey established the homogeneity of clusters and
neither stratification nor matching was performed. Sample size was based on increasing HIV-free survival from 74%
to 84%, and calculated to be 120 pregnant women per cluster. Primary outcomes are higher levels of HIV free
survival and levels of exclusive and appropriate infant feeding at 12 weeks postnatally. The intervention is home
based with community health workers delivering two antenatal visits, a postnatal visit within 48 hours of birth, and
a further four visits during the first two months of the infants life. We are undertaking programmatic and cost
effectiveness analysis to cost the intervention.
Discussion: The question is not merely to develop an efficacious package but also to identify and test delivery
strategies that enable scaling up, which requires effectiveness studies in a health systems context, adapting and
testing Asian community-based studies in various African contexts.
Trial registration: ISRCTN: ISRCTN41046462
* Correspondence: markt@sun.ac.za
1Department of Psychology, Stellenbosch University, Stellenbosch, Private
Bag X1, Matieland, 7602, South Africa
Full list of author information is available at the end of the article
Tomlinson et al. Trials 2011, 12:236
http://www.trialsjournal.com/content/12/1/236 TRIALS
© 2011 Tomlinson et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Background
South Africa has been spotlighted as one of only a
dozen countries worldwide where child mortality has
increased since the baseline for the Millennium Devel-
opment Goal 4 (MDG4) for child survival was set in
1990 [1]. This is primarily related to the HIV epidemic
and more than half of the child deaths are attributed to
HIV/AIDS, but much less attention is given to the fact
that 30% of under five deaths in South Africa are neona-
tal - deaths in the first 28 days of life [2]. Progress
towards MDG4 in South Africa will depend largely on
scaling up effective prevention against mother to child
transmission (PMTCT) of HIV and also addressing neo-
natal mortality. This same time period is critical for
maternal survival and health (MDG5). This imperative
drives increasing focus on the neonatal period and parti-
cularly on the development and testing of appropriate
models of sustainable, community-based care in South
Africa in order to reach the poor, especially the peri-
urban poor. A number of key implementation gaps
affecting progress have been identified [2-4].
1. Implementation gaps for HIV prevention in neonates
South Africa is one of the highest HIV prevalence coun-
tries in the world and has the single largest number of
people living with AIDS. Although the HIV prevalence
appears to be levelling off at around 30% of pregnant
women, this means that around 300, 000 women and
their babies require identification, support and appropri-
ate care [2]. Reducing MTCT of HIV is a major policy
and programmatic priority and with increasing political
support, more investment has focused on implementing
effective ARV prophylaxis regimes. As is the case in
much of Africa, coverage of PMTCT services in South
Africa is sub optimal. Although HIV testing of pregnant
women has increased steadily from 49% in 2005 to 86%
in 2008, less than half of HIV positive pregnant women
receive CD4 testing and coverage of infant six week
PCR testing is even lower [5]. However appropriate
infant feeding practices around birth and the first few
weeks of life are also critical and as yet success is elu-
sive. MTCT may occur during breastfeeding but the
greatest risk is with mixed feeding. In South Africa
exclusive breastfeeding rates are 7% [6]. In Umlazi data
from the Good Start study found that less than half
(46%) of HIV-positive women were able to practice
either exclusive formula feeding or exclusive breastfeed-
ing. Of the HIV-positive women who intended to EBF,
less than 2% practiced EBF. These results are similar to
those in rural South Africa [7]. The commonest reason
given for introducing additional fluids during the first
48 hours of life was “insufficient breastmilk”. From week
one to week 16, additional fluids and semi-solids were
given for an “unsatisfied baby” or “perceived milk
insufficiency”. It has been shown that intensive counsel-
ling and support can increase the proportion of women
who breastfeed exclusively [8-10]. However there are
considerable variations in the type of counselling sup-
port provided and many of these interventions were
very intensive and unlikely to be scaleable within an
overstretched health system, particularly if the peer
counsellor’s sole responsibility is feeding support and
not additional tasks. Disclosure of HIV status remains a
major constraint in effective counselling and behaviour
change.
2. Implementation gaps for neonatal care especially
home postnatal care
Globally neonatal deaths are an increasing proportion of
under-five deaths [3]. Despite considerable gains in
improving global child health, and in reducing child
mortality after the first month of life (month 2 to age 5
years), the same gains have not been made in reducing
neonatal mortality. Now 41% of all deaths in children
under five occur in the neonatal period [11]. The neona-
tal mortality rate in South Africa is 21 per 1000 live
births [2], although this differs markedly across regions
in South Africa, and for the poorest. A baby in Western
Cape may have access to full intensive care, yet a baby
in rural Eastern Cape may not receive basic care. The
newborn health component of maternal and child health
programmes has been a missing link, and a continuum
of care between homes and the health care system is
key for newborn care practices and survival [12]. An
increasing number of studies in South Asia have exam-
ined community based packages for newborn care,
reporting reductions in neonatal mortality of up to 70%
[13-15], but as yet no such studies have been published
from Africa, and none that also included PMTCT. The
United Nations recently released a joint statement on
the importance of home postnatal care for mothers and
newborns [16], yet South Africa does not have such a
package, or as yet a worker to provide such care.
3. Implementation gap for maternal mental health
support
A third implementation gap at the time of birth in low
and middle income countries is the dearth of interven-
tions aimed at improving maternal mental state and
addressing the effects that this has on child development
[4]. Several recent studies have provided data on how
maternal depression impacts infant physical growth,
how improved mother-infant interaction improves
breastfeeding and infant and child development, and
finally, a recent randomized controlled trial has provided
evidence of the benefits of an early community based
intervention with mothers and their infants [17]. An
intervention aimed specifically at preventing or treating
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maternal depression may not be cost effective in a
developing world context, although Rahman and collea-
gues have shown the benefits of a community based
intervention targeting depressed women [18]. This inter-
vention however is embedded within the tasks of an
existing cadre of Lady Health Visitors who deliver a ser-
ies of health interventions in Pakistan. There is a possi-
bility however, that the delivery of messages about
maternal mood within an integrated package of home
visits, together with the supportive counselling aspect
provided by the CBHW’s, may impact maternal mood.
Scientific rationale for integrated package to be tested
There is an urgent need to develop and implement an
evidence based, cost-effective package that can be deliv-
ered on a wide scale including reaching the poorest
families, in order to achieve key linked outcomes around
the time of birth - reducing neonatal mortality, prevent-
ing mother to child transmission of HIV, and impacting
maternal mood. Integration of HIV/AIDS PMTCT pro-
grammes with neonatal and childcare packages would
contribute to improved HIV free survival, maternal
health and also promote more efficient and effective use
of resources in this key time period. A review of a vari-
ety of integrated service delivery packages has previously
suggested 8 integrated MNCH packages which also
include PMTCT of HIV [19], and this global set has
been adapted for national application in South Africa to
also include the referral level (Figure 1) [2].
Our focus is on the community and primary care
level, and on the time period of pregnancy, birth, the
postnatal period and early weeks of life. Figure 2
illustrates our conceptualisation of this integrated
maternal, newborn and child health care package and
the relevant outcomes. It is envisaged that the MNCH
package (antenatal, postnatal and illness detection
and referral elements) will improve access to and
uptake of PMTCT which in turn, either directly or
indirectly, will lead to higher levels of appropriate
feeding. The outcome of this will be improved HIV
free survival.
Postnatal including 
Newborn
Pre-pregnancy Pregnancy Birth Childhood
Fa
m
ily
 a
nd
 
co
m
m
un
ity
O
ut
pa
tie
nt
 &
 
m
at
er
ni
ty
 u
ni
t
R
eg
io
na
l 
ho
sp
ita
l
ANTENATAL CARE
Basic antenatal care 
package with 
prevention of HIV 
mother-to child 
transmission and care 
for women
POSTNATAL CARE
•Early detection & referral of 
complications
•Support for infant feeding 
choices
•HIV testing for infants at 6 
weeks
CHILD CARE
Immunisations
Growth monitoring and promotion
Integrated Management of 
Childhood Illness integrated with 
care of children with HIV including 
cotrimoxazole
EMERGENCY PREGNANCY AND 
CHILDBIRTH CARE
Care for normal birth
Care for high risk pregnancies and 
immediate newborn care including 
resuscitation 
EMERGENCY NEWBORN AND CHILD CARE 
Care for sick children including those with HIV&AIDS, based on Integrated 
Management of Childhood Illness principles
Extra care of preterm babies including Kangaroo Mother Care
Emergency care for sick newborns
REPRODUCTIVE 
CARE
Termination of pregnancy
Post-abortion care
Treatment of complicated 
sexually transmitted 
infections
REPRODUCTIVE 
HEALTH CARE
•Family planning
•Prevention and care of 
sexually transmitted 
infections and HIV&AIDS 
•Preconception folic acid
•Healthy behaviours, e.g. maternal nutrition, 
reduced work load 
•Danger sign recognition, and emergency 
preparedness
•Appropriate home care of babies – appropriate feeding, avoiding 
hypothermia, hygienic cord/skin care, extra care for preterm babies
•Good nutrition, including complementary feeding
•Demand for key preventive services such as immunisations 
•Recognition of danger signs and appropriate care-seeking
Intersectoral Improved living conditions – Housing , water and sanitation, nutrition
Education and empowerment
•Adolescent and pre-
pregnancy nutrition
•Prevention of HIV and 
sexually transmitted 
infections
D
is
tr
ic
t 
ho
sp
ita
l 
BASIC CHILDBIRTH 
CARE
Care for normal birth and 
immediate newborn care 
including resuscitation
Prevention of mother-to 
child transmission of HIV
SPECIALIST OBSTETRIC  AND GYNAECOLOGICAL CARE SPECIALIST NEONATAL AND PAEDIATRIC CARE
Co
nn
ec
ti
ng
 le
ve
ls
 o
f c
ar
e 
–
co
m
m
un
ic
at
io
n 
an
d 
tr
an
sp
or
t
Figure 1 Integrated healthcare packages for maternal, newborn and child health according to level of the health system in South
Africa. Source - Chopra et al [2] adapted from Kerber et al [19].
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Our study seeks to address gaps in previous research
undertaken in South Africa namely a focus on the neona-
tal period and linking community based care with pri-
mary health care services. The first week after birth is the
period during which most neonatal deaths (as well as
most maternal deaths) occur and which is also most cru-
cial in preventing MTCT. Interventions that better link
the household and community level, and which bring
skilled community health workers closer to communities
have the potential to not only make a significant contri-
bution to reducing mortality, but also to empowering
communities. In many countries there is renewed interest
in strengthening community based care and in evaluating
what can be achieved for maternal, newborn and child
survival at community level [20]. Effective counselling at
home has been found to be more powerful than “health
education” in a clinical setting [21]. The question is not
merely to develop an efficacious package but also to iden-
tify and test delivery strategies that enable scaling up,
which requires effectiveness studies in a health systems
context, adapting and testing existing models in the Afri-
can context. Intervention strategies need to be based in
evidence as well as being culturally appropriate [22].
Policy context
The South African government is committed to meeting
the MDG 4 target and were PMTCT and newborn care
to be scaled up at full coverage this would put South
Africa on target [2]. The South African National Depart-
ment of Health (SANDOH) has also acknowledged that
in order to increase the likelihood of meeting the health
MDGs, the health system needs to be strengthened
through re-engineering of the current PHC approach.
Lessons learnt from the success of Brazil’s Unified
Health Programme/Family Health Programme, has led
to the revision of the SANDOH PHC service package in
2010. The PHC approach will change from a passive,
curative-oriented and based on individual health care to
a proactive population-based approach utilising commu-
nity based health workers (CBHWs) [23].
One major component of this new PHC plan is to
employ CBHWs as generalist health workers. While com-
munity workers in this study are part of a research study
rather than government hired and trained generalist com-
munity workers, every effort has been made to ensure that
all aspects of the training, implementation and supervision
of the community workers approximates interventions
currently being planned by the South African government.
In addition, the package promotes linkages between com-
munity level and existing health systems.
Methods
Study aim and objectives
The goal of this study is to develop, evaluate and cost
an integrated and scaleable home visit package delivered
by community health workers targeting pregnant and
postnatal women and their newborns to provide essen-
tial maternal/newborn care as well as interventions for
Prevention of Mother to Child Transmission (PMTCT)
of HIV using a cluster randomized controlled trial
design. We hypothesise that mothers and infants in
intervention clusters will have
○ Higher levels of HIV free survival and levels of
exclusive and appropriate infant feeding at 12 weeks
postnatally
○ Better uptake of a postnatal clinic visit within 7 days
of life
○ Better coverage of care and behavioural indicators
(antenatal HIV testing, uptake of cotrimoxazole amongst
HIV exposed infants at 6 weeks, family planning uptake
at 6 weeks)
Secondary objective:
○ To assess post intervention levels of maternal
depression at 12 weeks postpartum
Study context
The site for the intervention is Umlazi which is a peri-
urban settlement with a total population of 1 million
close to Durban in KwaZulu Natal that has a mixture of
formal and informal housing. The infant mortality rate
is around 60/1000 live births, while there is no reliable
figure of the neonatal mortality rate, most estimates
place the NMR at about 25/1000 live births. The HIV
prevalence amongst antenatal clients in this district was
41% in 2009 [24] Over 98% of all births in Umlazi occur
in one major hospital.
Study Design
Cluster selection and cluster size
The trial consists of 30 randomized clusters (15 in each
arm). Maps were obtained that divided the area into
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Figure 2 An integrated community based MNCH and PMTCT
package to improve HIV free survival.
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“sub-places”. Following the drawing of clusters a base-
line survey of all clusters was conducted in order to
check the homogeneity of clusters. Results of this exer-
cise established the homogeneity of clusters and neither
stratification nor matching was performed.
Sample and sample size
The study sample is all pregnant women and their new-
borns in the cluster during the recruitment period who
give informed consent for study participation. Sample
size was calculated based on increasing HIV-free survi-
val from 74% to 84%, with 80% power in an individually
randomised trial (this would require 279 live births per
arm). Assuming an ICC of 0.04 for a cluster randomised
trial calculated that we would need 750 HIV exposed
children per arm (50 per cluster) with a design effect of
3. Loss to follow up of approximately 20% was added to
this sample size. Based on an HIV prevalence rate
amongst pregnant women of 40% our sample size was
calculated to be 120 pregnant women per cluster.
Study procedures
Recruitment
In intervention clusters, CBHW’s identify pregnant
women and encourage them to seek antenatal care.
CBHW’s also inform pregnant women about the study
that is being conducted on infant feeding and child
health. In control clusters a CBHW recruits all pregnant
women. CBHW’s in control clusters provide key infor-
mation and support to the mother on how to obtain
social welfare grants, particularly the Child Support
Grant. The grant package in the control arm comprises
one visit during the antenatal period to provide the
necessary information regarding requirements for a
grant application. As these grants normally take a few
months to be processed, there is a visit at 4-6 weeks
postnatally to follow up the grant application and to
assist in resolving any difficulties. There is also a visit by
CBHW’s in the control arm at 10-12 weeks with the
main aim of reminding women to go to the assessment
site when their infant is 12 weeks old for data collection.
The size of intervention and control clusters are the
same. All efforts have been made to avoid contamina-
tion between control and intervention arms. The
focussed, one on one, and individualised nature of the
intervention in itself, significantly limits the possibility
of contamination. On a weekly basis the data collectors
are given the cards of women identified by the CBHW’s.
They go to the mother’s homes to inform them about
the study in detail and obtain written, informed consent
from mothers who wish to participate in data collection.
They ask mothers if they underwent counselling and
HIV testing at the antenatal clinic and ask if the mother
is willing to disclose her test result. The activities of the
CBHW’s and data collectors are kept completely
separate.
In order to ensure that CBHW’s are able to visit
women in the first 24 hours following birth we have
employed a part-time person in the Prince Mshiyeni
hospital where over 98% of all births in Umlazi take
place. The person obtains daily records of all births in
the Prince Mshiyeni hospital, and contacts (via the
mobile phone system and web interface) CBHW’s when
an intervention group participant gives birth.
Intervention
CBHW’s were trained in the intervention over the
course of two weeks. The training included the exten-
sive use of role plays that were video recorded and
then used for teaching and supervision purposes. The
intervention is a structured home visiting programme
with antenatal and postnatal visits with specific con-
tent covered at each visit. These community level
interventions along the continuum of care link to the
existing health system packages delivered through
outreach (antenatal, some postnatal visits and preven-
tive child health care and clinical care at facilities
including obstetric and emergency newborn and child
care). In each intervention cluster there is one CBHW
who covers all households in the cluster. The content
and conduct of the intervention is specified in a man-
ual which is used to train community workers, linking
to existing PMTCT, Integrated Management of Child-
hood Illness (IMCI) and newborn care guidelines.
There are various linkages between all the pro-
grammes mentioned above that aid the process of
programme integration.
The visits in the intervention arm are as follows (see
Table 1 for visit content):
○ Two antenatal visits
○ Visit in the first 24-48 hours.
○ Visit at day 3 or 4
○ Visit at 10-14 days
○ Visit at 3-4 weeks
○ There will then be a routine clinic visit at 6-7
weeks
○ Final visit at 7-8 weeks
All neonates that weigh under 2500 g that are released
from hospital within 24 hours receive two extra visits.
Neonates that weigh under 1500 g and when there are
concerns about birth weight may be kept under observa-
tion at Prince Mshiyeni hospital. The discharge date of
these neonates is considered as the date of birth for the
purposes of the timing of visits. Extra time in hospital
(more than 3 days) will be used as a marker for illness
or low birth weight, and these mother infant dyads will
receive an extra two visits during the first week at home.
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Content of the visits
We have developed a package based on a review of
existing evidence and taking the local context into
account structured around a series of homes visits with
specific tasks for each visit. These visits will also link to
and promote visits in clinics and be timed to maximise
uptake of the facility visits. CBHW’s are provided with a
book/flip chart book that contains details of material to
be covered during visits. This is not designed as educa-
tion material to be presented to participants but rather
as a reminder to ensure that core messages are commu-
nicated during visits.
Health facility strengthening
A central component of the package is to promote lin-
kages between community level and existing health sys-
tems. The Partnership Defined Quality (PDQ) approach
Table 1 Visit schedule and content
Antenatal visit 1 at HOME Antenatal care action - immunisations/micronutrient supplementation
Focus on the importance of VCT (linking this with the PMTCT programme and the benefits of testing to the
mother)
Emphasise the importance of antenatal care
Key messages on appropriate infant feeding
Encourage exclusive breastfeeding in HIV negative women or women of unknown HIV status.
For HIV positive women, assist with thinking about infant feeding options
Input regarding infant communication and the mother-infant relationship
Antenatal visit 2 at home Birth plans - place of birth, support during labour, care plans if returning to work
Danger signs and emergency plans - this will be done, if possible together with other family members in order to
elicit their input regarding possible plans in the event of an emergency, including recognition of danger signs,
emergency transport plan and emergency funds if needed
Homecoming arrangements
Follow up and re-emphasis on VCT, PMTCT, the key messages on appropriate infant feeding that were provided in
antenatal visit 1; further discussion in terms of assisting with the implementation of chosen feeding option
Additional input on infant communication and the warning signs of postnatal depression
Postnatal visit 1 at home
(24-48 hrs)
Assessment of newborn-breathing, thermal care, colour, bleeding, neonatal eye care, checklist of danger signs
Assessment of mother - bleeding, signs for infection, mastitis
Early recognition of illness (superficial or systemic) and help seeking
Exclusive breastfeeding or appropriate infant feeding support
Hygienic cord care and what to expect regarding when the cord will drop off
Thermal care, skin to skin care and Kangaroo care if needed for preterm babies
Ensure that babies of HIV positive women have received Nevirapine
Information about warning signs for mother or baby and what to do
Support for women who have ‘the blues’
Postnatal visit 2 at home (3-
4 days)
Assessment of the mother and the newborn, Further input on the early recognition of illness (superficial or
systemic) and help seeking
Monitoring and follow up of breastfeeding or appropriate feeding and possible feeding problems
Further support for hygiene, thermal care and cord care, with Kangaroo care input if needed for preterm babies
1st week clinic visit reminder
Information about warning signs for mother or baby and what to do
Newborn Interactive Assessment - demonstration of the abilities of infants and infant communication and social
responsiveness. Sleeping, crying, consolability and wider concerns
Postnatal visit 3 at home
(10-14 days)
Early recognition of illness (superficial or systemic) and help seeking
Ongoing monitoring of breastfeeding or other appropriate feeding
Information about warning signs for mother or baby and what to do
Promote attendance at clinic for 6 week visit for mother to have access to family planning and baby to receive
immunisations and the babies of HIV+ women been given bactrim and HIV testing
Mother infant interaction modelling and communication input
Assess for signs of postnatal depression
Postnatal visit 4 at home (3-
4 weeks)
Early recognition of illness (superficial or systemic) and help seeking
Ongoing monitoring of breastfeeding or other appropriate feeding
Information about warning signs for mother or baby and what to do
Promote attendance at clinic for 6 week visit for mother to have access to family planning and baby to receive
immunisations and the babies of HIV+ women been given bactrim and HIV testing
Mother infant interaction modelling and communication input
Assess for signs of postnatal depression
Postnatal visit 5 at home (7-
8 weeks)
Further input on feeding including advice regarding weaning
Infant weight from clinic card (6 week visit)
Mother infant attachment
Checklist of signs of postnatal depression
Has the child been tested for HIV at six weeks and receiving cotrimoxazole
Formula sustainability for HIV positive women using formula milk
Family planning and counselling
Input on milestones and information and specific skills about the stimulation of infants
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works to reach marginalized populations and address
underlying causes of health problems such as discrimi-
nation, social, economic, cultural, political and organiza-
tional conditions through addressing the quality of
health services [25]. An integral part of this process
involves providing community members and health
facility providers with the skills and systemic support
they need to improve health service quality and access
to these services. The PDQ process is a collaborative
approach to exploring health quality, identifying com-
mon issues and creating a common platform for com-
munities and health service providers to work towards
improving health quality service delivery. The PDQ pro-
cess encourages and support communities and health
services to actively participate together towards improv-
ing health quality through on ongoing dialogue, plan-
ning, collective action and monitoring of outcomes
leading towards increased demand for and access to
health services. We are implementing a PDQ process in
two local clinics in Umlazi.
Data collection
Two types of data are consistently monitored:
1) Medical record reviews are conducted on the Road
to Health card for each participant, extracting informa-
tion on routine health data including HIV test results,
CD4 count, tuberculosis, and PMTCT medications used,
such as AZT and NVP. Delivery data, such as the date
of delivery, baby weight and height, birth complications,
and data from postnatal screening (vitamins dispensed,
mother’s TB and HIV test results, and the baby’s weight,
height, PCR test results, and immunisations) are also
collected from the hospital delivery records.
2) In-person interview assessments. Structured inter-
view guides have been developed for interviews with
participants at 12 weeks postpartum. Interviews are
administered by trained interviewers at the study office
in Prince Mshiyeni hospital in Umlazi (see Table 2 for a
list of process and outcome measures).
In addition key process documentation will include an
assessment of the process involved in training and
supervising community workers, and the retention of
CBHW’s and factors affecting motivation and intensity
of the intervention (coverage of scheduled visits).
Economic evaluation
Costing is a critical component of an effectiveness trial
to inform scale up, and we are undertaking programma-
tic and cost effectiveness analysis. The economic evalua-
tion is divided into the costing and cost-effective
analysis (CEA). Both analyses will be conducted from a
provider’s perspective. The costs will be measured pro-
spectively using a tool developed by two of the authors
(ED and LN). The tool built on the gaps of existing
tools [26]. The costing methodology will be an activity
based costing using an ingredients approach [27-29].
The outputs of the intervention will be calculated (i.e.
cost per visit and cost per woman).
In order to inform scale up process the costs will be
presented as set-up costs (one-off and repeatable) and
implementation costs. The use of the term scale up in
this context refers to two processes; increasing coverage
within the same district or geographical area and
expanding coverage to other districts or geographical
area. One-off and repeatable set up costs will be pre-
sented to highlight cost consequences for these different
aspects of scale-up mentioned above. For both aspects
of scale up one off and set-up costs will not be incurred
again, examples of these costs are development of the
content of the intervention and manual development.
On the other hand, if the intervention is expanded to
other districts, repeatable set-up costs will be incurred.
These include recruitment and training of community
health workers and their supervisors. If there is an exist-
ing cadre of community health workers and supervisors,
and they have additional capacity (i.e. e time), recruit-
ment costs (repeatable scale-up) and other implementa-
tion costs will not be applicable; this will translate to a
reduction in unit costs (cost per visit). Another factor
that affects scale-up is human resource requirements. In
this trial the time use of community health workers has
been captured in detail. This information will be useful
establishing whether community health workers can
take on additional activities or not. At facility level,
recurrent cost-items consumed, and staff time will be
measured. The purpose of this exercise will be to cap-
ture the consequences of the intervention at this level.
CEA for the intervention will be undertaken based on
findings from the costing studies and the trial described
in this proposal. One of the trials primary outcome
measures is HIV free survival at 12 weeks. Therefore,
cost-effectiveness will be measured in terms of cost per
Disability adjusted life year averted. The CEA will be
stochastic to account for the level of uncertainty uncov-
ered in the trial [30].
Data collection strategy
Mobile phones are used for collecting data at the 12
week endpoint as well as for monitoring the interven-
tion delivery. Programming and bench testing of mobile
phones for collection of assessment interviews was con-
ducted for several months. Data is collected on mobile
phones running a survey software package (Mobile
Researcher; http://www.populi.net/mobileresearcher/).
This platform allows the phone to be used to collect
and upload numeric, voice and text data. The mobile
phone models used in the study are the Nokia 5000 for
data collection and 1680 for monitoring the intervention
delivery. Initial training covers practical aspects of
phone navigation, checking for software updates, use of
the software, and uploading data to the central server.
Tomlinson et al. Trials 2011, 12:236
http://www.trialsjournal.com/content/12/1/236
Page 7 of 9
Staff then spent two weeks familiarising themselves with
the baseline survey on the phone. During this time mul-
tiple tests were run to ensure that all data entered on
the phone were uploaded and that the response entered
on the mobile corresponded to the value stored in the
database [31].
Determining HIV transmission rates
Dried blood spots (DBS) are collected from study infants
of HIV infected mothers by means of a heel prick dur-
ing the 12 weeks interview and tested using DNA PCR
testing. The DBS samples are collected by Field
Researchers who will have been trained in the proce-
dure. Training included fully informing field researchers
of the risks, the need to take universal precautions and
on procedures related to accidental needle-prick injuries.
Data analysis
Analyses will include descriptive and analytic statistics
pertaining to research questions. Categorical data will be
analysed using frequencies, cross-tabulations with chi-
square and 95% confidence intervals for the risk ratio or
risk difference. Continuous data will be analysed using
means and variance, and comparison of mean differ-
ences and 95% confidence intervals around the mean
difference. Kaplan-Meyer analysis will be used for esti-
mating HIV transmission rates. Stratified analysis, logis-
tic regression or Cox regression will be used to adjust
for potential confounding in the data. Analysis will be
on an intention to treat basis and we will ensure that
the cluster randomized design will be accounted for in
the analysis.
Collaboration
The study is a collaborative effort between the Health
Systems Research Unit, Medical Research Council
(Tanya Doherty, Ameena Goga, Petrida Ijumba), Saving
Newborn Lives/Save the Children (Joy Lawn), Stellen-
bosch University (Mark Tomlinson), University of Wes-
tern Cape (Debra Jackson, David Sanders), Maromi
Health Research (Mark Colvin), Uppsala University
(Lars Ake Perrson) and UNICEF (Mickey Chopra).
Research ethics and approval
The ethics review board of the Medical Research Coun-
cil (EC08-002) has approved and monitors the study
protocol over time. We have established a Community
Advisory Board (CAB) that consists of a number of
local stakeholders who act as a liaison between the com-
munity and research staff and management. The CAB
also provides feedback to the community about study
progress. Hospital and provincial authorities are also
provided with regular feedback about the study.
Discussion
The goal of the study is to develop an integrated and
scaleable home visit package delivered by community
health workers targeting pregnant and postnatal women
and their newborns to provide essential maternal/new-
born care as well as increasing uptake of interventions
for Prevention of Mother to Child Transmission
(PMTCT) of HIV. Integration of Prevention of Mother to
Child Transmission of HIV/AIDS (PMTCT) programmes
with maternal, neonatal and child health care packages to
ensure reduction in mother to child transmission and
promote more efficient and effective use of resources in
this key time period is critical. A limitation of the study is
the early outcome assessment at 12 weeks. Whilst this is
a suitable time to collect outcomes related to newborn
caring and early health care seeking, it will only allow for
an assessment of early mother to child transmission and
not later postnatal transmission which would require
much longer and more costly follow up.
Table 2 Outcome measures
Mortality, growth and HIV
status
Neonatal mortality rate (deaths in the first 28 days of life, per 1000 live births)
Identification of HIV status in infants at 12 weeks using PCR testing
Infant weight and length at 12 weeks
Coverage of care Co-trimoxazole initiation amongst HIV exposed infants at 6 weeks
Clinic visit within the 1stweek
Having received a postnatal care visit by a CBHW within 48 hours
Assessment of biological markers of illness such as diarrhoea
Assessment of uptake of HIV specific care and treatment for HIV positive families
Key behaviours Infant feeding patterns will be recorded through 24 hour and previous three-day recall
Participation in ANC, VCT, Well-child, Post-partum and PMTCT services
Satisfaction with ANC, Delivery, Newborn, Post-partum and PMTCT services
HIV status disclosure
Maternal care behaviours of infant cleanliness, warmth
Positive behaviours such as the occurrence of immediate (first hour of life) and exclusive breastfeeding at six weeks.
Infant feeding patterns will be recorded through 24 hour and previous seven-day recall at 12 weeks.
Maternal care-seeking behaviour for infant illness, detection of illness - recognizing signs and severity will be recorded
at 12 weeks
Use of dual protection methods for family planning and HIV/STD prevention recorded at 12 weeks
Maternal mental state assessed at 12 weeks
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This study has a number of innovative aspects. Firstly
this is an integrated package that is in line with a global
focus on maternal and child health care but more
importantly falls squarely within South African govern-
ment policy of promoting integrated maternal, neonatal
and child health. The mechanisms that have been put in
place to ensure early (24-48 hours) home visits by
CBHW’s in the community is central to the reduction
of neonatal mortality. Secondly, the use of mobile
phones and a web-based interface aids in data collection
but more importantly is proving to be an invaluable tool
in the management and supervision of CBHW’s.
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